Patients With Moderate-to-severe COPD With Destroyed Lung by Tuberculosis

Explore clinical trials studying Patients With Moderate-to-severe COPD With Destroyed Lung by Tuberculosis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Patients With Moderate-to-severe COPD With Destroyed Lung by Tuberculosis trial results

Completed

Indacaterol EfectIveness In COPD Patients With Tuberculosis History

NCT01778062

Conditions: Patients With Moderate-to-severe COPD With Destroyed Lung by Tuberculosis
Locations: Novartis Investigative Site Anyang-si, Gyeonggi-do, South Korea

Novartis Investigative Site Koyang-si, Gyeonggi-do, South Korea

Novartis Investigative Site Jeonju, Jeollabuk-do, South Korea

Novartis Investigative Site Seoul, Korea, South Korea

View all 13 locations

View Trial Details